Table 3.
Pathway descriptions | No. of genes | LS P‐value | KS P‐value | Related pathways |
---|---|---|---|---|
VEGF, hypoxia, and angiogenesis | 23 | 0.0018 | 0.0270 | Angiogenesis |
Hypoxia‐inducible factor in the cardiovascular system | 26 | 0.0055 | 0.0023 | Angiogenesis |
Role of nicotinic acetylcholine | 13 | 0.0075 | 0.1485 | N/A |
Melanocyte development and pigmentation pathway | 14 | 0.0093 | 0.1461 | N/A |
Transcription regulation by methyltransferase of CARM1 | 20 | 0.0097 | 0.0378 | N/A |
Classical complement pathway | 6 | 0.0141 | 0.0018 | N/A |
Role of Tob in T cell activation | 26 | 0.0146 | 0.0097 | T cell |
Lectin‐induced complement pathway | 6 | 0.0180 | 0.0018 | N/A |
Deregulation of CDK5 in Alzheimer's disease | 20 | 0.0193 | 0.0054 | N/A |
IL‐12‐ and Stat4‐dependent signaling pathway in Th1 development | 37 | 0.0254 | 0.0078 | T cell |
T cell receptor and CD3 complex | 15 | 0.0283 | 0.0023 | T cell |
NOS2‐dependent IL‐12 pathway in NK cells | 14 | 0.0350 | 0.0031 | T cell |
T cytotoxic cell surface molecules | 28 | 0.0354 | 0.0072 | T cell |
T helper cell surface molecules | 28 | 0.0354 | 0.0072 | T cell |
Role of MEF2D in T cell apoptosis | 31 | 0.0358 | 0.0097 | T cell |
HIV‐induced T cell apoptosis | 24 | 0.0442 | 0.0012 | T cell |
ADP‐ribosylation factor | 38 | 0.0485 | 0.0087 | N/A |
CARM1, coactivator‐associated arginine methyltransferase 1; IL, interleukin; NK, natural killer; Stat4, signal transducer and activator of transcription‐4; N/A, not applicable; VEGF, vascular endothelial growth factor.